CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 3,902 enrolled
Drug / intervention
Surgery on the ascending aorta with or without repair of the aortic root and/or aortic archprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04831073
NCT04831073N/ACompleted

European Registry of Type A Aortic Dissection

Helsinki University Central Hospital·observational·Posted Apr 5, 2021·Updated Dec 11, 2024

In Brief

An observational study evaluating Surgery on the ascending aorta with or without repair of the aortic root and/or aortic arch for Type A Aortic Dissection. Completed, enrolled 3,902 participants across 20 sites in 8 countries.

Detailed Summary

Acute Stanford type A aortic dissection (TAAD) is a life-threatening condition. Surgery is usually performed as a salvage procedure and is associated with significant postoperative early mortality and morbidity. Understanding the patient's conditions and treatment strategies which are associated with these adverse events is essential for an appropriate management of acute TAAD.

Study Details

Timeline

N/ACompletedFinished
20222023202420252026
First PostedApr 5, 2021
Enrollment StartFeb 28, 2023
Primary CompletionDec 6, 2024
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 5.2 years ago

Interventions

Surgery on the ascending aorta with or without repair of the aortic root and/or aortic archprocedure

Surgical repair of the ascending aorta with or without surgical repair of the aortic root and/or aortic arch